Cost-effectiveness of Electroconvulsive Therapy for Treatment-Resistant Depression in the United States episode artwork

EPISODE · May 9, 2018 · 6 MIN

Cost-effectiveness of Electroconvulsive Therapy for Treatment-Resistant Depression in the United States

from JAMA Psychiatry Author Interviews

Interview with Daniel Francis Maixner, MD, author of Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States

NOW PLAYING

Cost-effectiveness of Electroconvulsive Therapy for Treatment-Resistant Depression in the United States

0:00 6:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Psychiatry Author Interviews?

This episode is 6 minutes long.

When was this JAMA Psychiatry Author Interviews episode published?

This episode was published on May 9, 2018.

What is this episode about?

Interview with Daniel Francis Maixner, MD, author of Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States

Can I download this JAMA Psychiatry Author Interviews episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!